What is the advanced prostate cancer treatment for my uncle?

Question

Hello doctor,

My 67-year-old uncle's prostate cancer is not responding well to standard treatments, and his oncologist has suggested considering clinical trials. How safe are these trials, and do they actually improve survival rates for patients with advanced prostate cancer? What risks should we be aware of before making a decision? He is open to trying new options, but we want to ensure we are making an informed choice.

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Clinical trials can be a valuable option once standard treatments have failed, but there are both pros and cons to consider. While clinical trials have the potential to yield groundbreaking results, they can also carry the risk of life-threatening side effects. The outcomes depend on various factors, including the type of medications being tested, the stage of the disease, the areas affected, the patient's overall health, and any existing comorbidities.

There are currently multiple clinical trials underway, and some have shown promising results. For example, since 2023, the U.S. Food and Drug Administration (FDA) has approved the following treatment combinations for men with metastatic prostate cancer:

The hormone therapy Enzalutamide (Xtandi) combined with the PARP or Poly (ADP-ribose) polymerase inhibitor Talazoparib (Talzenna).
The hormone therapy Abiraterone (Zytiga) combined with the PARP inhibitor Olaparib (Lynparza).

These combinations have shown effectiveness in certain cases, but it is essential to weigh the potential benefits against the risks and discuss all available options with the oncologist to make an informed decision.

Revert with the answer to assist further.

Thank you and take care.